| |
|
| Listing by Phase and Title |
Return to index selection |
| Phase: |
|
C18
C18, LC-MS |
|
C8
C8, LC-MS/LC-UV |
|
RP-Amide
RP-Amide, LC-MS/ LC-UV |
|
|
|
| Ascentis C18 |
back to top |
| Title |
Application
Report No. |
| Acebutolol and Pindolol Antihypertensives Using Ascentis C18, Analysis of |
95 |
| Analgesics Using Ascentis C18, Analysis of |
85 |
| Angiotensins Using Ascentis C18, Analysis of |
231 |
| Antiulceratives Using Ascentis C18, Analysis of |
233 |
| Antibacterials Using Ascentis C18, Analysis of |
82 |
| Antibiotic Sulfa Drugs Using Ascentis C18, Analysis of |
87 |
| Anticholinergics Using Ascentis C18, Analysis of |
88 |
| Anticonvulsants Using Ascentis C18, Analysis of |
218 |
| Antihistamines Using Ascentis C18, Analysis of |
92 |
| Antiemetic Meclizine Using Ascentis C18, Analysis of |
91 |
| Antihypercholesterolemic Mevinolin (Levostatin) and Degradation Products Using Ascentis C18, Analysis of |
229 |
| Antihypertensive Metoprolol and Hydroxy Metabolite Using Ascentis C18, Analysis of |
93 |
| Antihypertensive Propranolol and Hydroxy Metabolite Using Ascentis C18, Analysis of |
94 |
| Antihypertensives Using Ascentis C18, Analysis of |
96 |
| Anti-inflammatory Drugs Using Ascentis C18, Analysis of |
97 |
| Antimicrobial Furazolidone Using Ascentis C18, Analysis of |
98 |
| Antineoplastic Using Ascentis C18, Analysis of |
199 |
| Antineoplastic Using Ascentis C18, Analysis of |
99 |
| Antiparkinsonian Using Ascentis C18, Analysis of |
100 |
| Antipsychotics Using Ascentis C18, Analysis of |
101 |
| Anxiolytic Using Ascentis C18, Analysis of |
102 |
| Aromatic Compounds Using Ascentis C18, Separation of |
279 |
| Atrazine Metabolites Using Ascentis C18, Analysis of |
255 |
| Barbitals Using Ascentis C18, Analysis of |
216 |
| Benzoic Acid Derivatives Using Ascentis C18, Analysis of |
270 |
| Bronchiodialator Terbutaline Using Ascentis C18, Analysis of |
103 |
| Calcium Channel Blocker Verapamil and Methoxy Metabolite Using Ascentis C18, Analysis of |
116 |
| Calphostin C Using Ascentis C18, Analysis of |
128 |
| Cannabinoids Using Ascentis C18, Analysis of |
83 |
| Cephalosporins Cefadroxil, Cephapirin, and Cefsulodin Using Ascentis C18, Analysis of |
106 |
| Cephalosporins Cefoxitin and Cephalothin Using Ascentis C18, Analysis of |
107 |
| Cephalosporins Cefprozil Z Isomer and Ceftriaxone Using Ascentis C18, Analysis of |
108 |
| Codeines Using Ascentis C18, Analysis of |
109 |
| Cold Remedy Ingredients Using Ascentis C18, Analysis of |
235 |
| Conjugated Estrogens Using Ascentis C18, Analysis of |
230 |
| Diuretics Furosemide and Indapamide Using Ascentis C18, Analysis of |
111 |
| EPA 8330 Mix A on Ascentis C18 |
330 |
| EPA 8330 Mix B on Ascentis C18 |
331 |
| Estrone, β-Estradiol, α-Estradiol, and Estriol Using Ascentis C18, Analysis of |
84 |
| Floxacin Antibacterials Using Ascentis C18, Analysis of |
110 |
| Herbicide Triazines Using Ascentis C18, Analysis of |
223 |
| Hydrophobic Bases Using Ascentis C18, Separation of |
198 |
| Hydrophobic Bases Using Ascentis C18, Separation of |
280 |
| Hydrophobic Peptide Probes Using Ascentis C18, Analysis of |
190 |
| 4-hydroxytamoxifen Isomers Using Ascentis C18, Analysis of |
346 |
| Ketoprofen and Related Compounds Using Ascentis C18, Analysis of |
333 |
| Nitrazepam Anticonvulsant Using Ascentis C18, Analysis of |
90 |
| NSAIDS Diclofenac and Salicylic Acid Using Ascentis C18, Analysis of |
112 |
| Parabens Using Ascentis C18, Analysis of |
206 |
| Penicillins Using Ascentis C18, Analysis of |
113 |
| Peptide Mixture Using Ascentis C18, Separation of a 5 |
281 |
| Pesticides Aldicarb, Carbofuran, and Atrazine Using Ascentis C18, Analysis of |
214 |
| Pesticides Carbaryl, Diuron, and Propachlor Using Ascentis C18, Analysis of |
208 |
| Phencyclidine and Hydroxy Metabolite Using Ascentis C18, Analysis of |
86 |
| Phenolic and Benzyl Compounds Using Ascentis C18, Analysis of |
225 |
| Phenolic Antioxidants Using Ascentis C18, Analysis of |
287 |
| Quinidine and its Derivatives Using Ascentis C18, Analysis of |
272 |
| Risedronate Using Ascentis C18, Analysis of |
328 |
| Steroids Using Ascentis C18, Analysis of |
114 |
| Sulfonylurea Urea Pesticides Using Ascentis C18, Analysis of |
241 |
| Tetracyclines Using Ascentis C18, Analysis of |
260 |
| Tranquilizer Fentanyl Citrate Using Ascentis C18, Analysis of |
115 |
| Tricyclic Antidepressants Using Ascentis C18, Analysis of |
239 |
| Ulcer Treatment Drugs Using Ascentis C18, Analysis of |
263 |
| Urea Pesticides Using Ascentis C18, Analysis of |
210 |
| US EPA Method 632 Carbamate and Urea Pesticides Using Ascentis C18, Analysis of |
308 |
| US EPA Method 632.1 Pesticides Using Ascentis C18, Analysis of |
285 |
| Vitamin D2 and Vitamin D3 Using Ascentis C18, Analysis of |
212 |
| Warfarin Anticoagulant Using Ascentis C18, Analysis of |
89 |
| Xanthines Using Ascentis C18, Analysis of |
127 |
|
|
| Ascentis C18, LC-MS |
back to top |
| Cannabinoids Using Ascentis C18, LC-MS Analysis of |
186 |
| Complex Peptide Mix Using Ascentis C18, LC-MS Analysis of |
118 |
| Complex Peptide Mixture Using Ascentis C18, LC-MS Analysis of |
173 |
| Enkephalin Derivative Using Ascentis C18, LC-MS Analysis of |
178 |
| Enkephalin Derivative Using Ascentis C18, LC-MS Analysis of |
119 |
| Galanthamine Using Ascentis C18, LC-MS Analysis of |
121 |
| Macrolide Antibiotics Using Ascentis C18, LC-MS Analysis of |
117 |
| (Basic) Peptide Probes Using Ascentis C18, LC-MS Analysis of |
120 |
| Rifampicin Using Ascentis C18, LC-MS Analysis of |
122 |
| Serotonin Metabolites Using Ascentis C18, LC-MS Analysis of |
123 |
| Synthetic Basic Peptide Probes on Ascentis C18, LC-MS Analysis of |
290 |
| Tryptophan Hydroxylase Inhibitors, LC-MS Analysis of |
291 |
| Tryptophan Hydroxylase Inhibitors Using Ascentis C18, LC-MS Analysis of |
124 |
| Veterinary Antibiotics Using Ascentis C18, LC-MS Analysis of |
125 |
| Veterinary Antibiotics at Elevated Temperature Using Ascentis C18, LC-MS Analysis of |
126 |
|
|
|
|
|
| Ascentis C8 |
back to top |
| Title |
Application
Report No. |
| Anabolic Androgenic Steroid Methandienone and Hydroxy Metabolite Using Ascentis C8, Analysis of |
321 |
| Anabolic Androgenic Steroids Using Ascentis C8, Analysis of |
319 |
| Analgesics Using Ascentis C8, Analysis of |
307 |
| Anesthetics Using Ascentis C8, Analysis of |
300 |
| Antiarrhythmics Using C8 Ascentis C8, Analysis of |
311 |
| Antiasthmatics Using Ascentis C8, Analysis of |
301 |
| Anticonvulsants Using Ascentis C8, Analysis of |
303 |
| Antidepressants Using Ascentis C8, Analysis of |
316 |
| Antiepileptic agents using Ascentis C8, Analysis of |
295 |
| Antifungal Agents Using Ascentis C8, Analysis of |
325 |
| Antifungal Agents Using Ascentis C8, Analysis of |
332 |
| Antihistaminics Using Ascentis C8, Analysis of |
297 |
| Antihypertensives Captopril and Quinapril Using Ascentis C8, Analysis of |
318 |
| Anti-inflammatory Therapeutics Using Ascentis C8, Analysis of 3 |
298 |
| Antineoplastics Using Ascentis C8, Analysis of |
304 |
| Antipsychotics Drugs Using Ascentis C8, Analysis of |
309 |
| Antivirals Using Ascentis C8, Analysis of |
310 |
| Cardiac Drugs Using Ascentis C8, Analysis of |
305 |
| Desogestrel and 17α-Ethynylestradiol Using Ascentis C8, Analysis of |
326 |
| Glucocorticoids Using Ascentis C8, Analysis of |
296 |
| Ketoprofen and Related Compounds Using Ascentis C8, Analysis of |
306 |
| LSD and Related Compounds Using Ascentis C8 with UV Detection, Analysis of |
338 |
| Menthol and Methyl Salicylate Using Ascentis C8, Analysis of |
323 |
| Organic Acids Using Ascentis C8, Analysis of |
302 |
| Phenolic Antioxidants Using Ascentis C8, Analysis of |
283 |
| Therapeutics Using Ascentis C8, Analysis of Structurally Diverse |
284 |
| Tricyclic Antidepressants Using Ascentis C8, Analysis of |
299 |
| US EPA Method 632 Carbamate and Urea Pesticides Using Ascentis C8, Analysis of |
320 |
| US EPA Method 632.1 Pesticides Using Ascentis C8, Analysis of |
286 |
|
|
| Ascentis C8, LC-MS / LC-UV |
back to top |
| Antibacterials Using Ascentis C8, LC-MS Analysis of |
335 |
| Antidepressants Using Ascentis C8, LC-MS Analysis of |
315 |
| Barbituates Using Ascentis C8, LC-MS Analysis of |
341 |
| Barbituates Using Ascentis C8, LC-UV Analysis of |
342 |
| Benzodiazepines Using Ascentis C8, LC-MS Analysis of |
343 |
| Benzodiazepines Using Ascentis C8, LC-MS Analysis of |
344 |
| Fentanyl and Norfentanyl Using Ascentis C8, LC-MS Analysis of |
336 |
| LSD and Related Compounds Using Ascentis C8, LC-MS Analysis of |
337 |
| Methadone and Metabolite Using Ascentis C8, LC-MS Analysis of |
339 |
| Methadone and Metabolite Using Ascentis C8, LC-UV Analysis of |
340 |
| Tricyclic Antidepressants Using Ascentis C8, LC-MS Analysis of |
312 |
| Tricyclic Antidepressants Using Ascentis C8, LC-MS Analysis of |
313 |
| Tricyclic Antidepressant Using Ascentis C8, LC-MS Analysis of |
314 |
|
|
|
|
|
| Ascentis RP-Amide |
back to top |
| Title |
Application
Report No. |
| Acebutolol and Pindolol Antihypertensives Using Ascentis RP-Amide, Analysis of |
137 |
| β-Agonists Roxarsone and Clenbuterol Using Ascentis RP-Amide, Analysis of |
150 |
| Analgesics Acetaminophen and Gentisic Acid Using Ascentis RP-Amide, Analysis of |
277 |
| Analgesics Using Ascentis RP-Amide, Separation of |
265 |
| Angiotensins Using Ascentis RP-Amide, Analysis of |
232 |
| Antibacterials Using Ascentis RP-Amide, Analysis of |
138 |
| Antibiotic Sulfa Drugs Using Ascentis RP-Amide, Analysis of |
148 |
| Anticholinergics Using Ascentis RP-Amide, Analysis of |
168 |
| Anticonvulsants Using Ascentis RP-Amide, Analysis of |
219 |
| Antiemetic Meclizine Using Ascentis RP-Amide, Analysis of |
159 |
| Antifungal Agents Using Ascentis RP-Amide, Analysis of |
327 |
| Antihypertensive Metoprolol and Hydroxy Metabolite Using Ascentis RP-Amide, Analysis of |
161 |
| Antihypertensive Propranolol and Hydroxy Metabolite Using Ascentis RP-Amide, Analysis of |
167 |
| Anti-inflammatory Drugs Using Ascentis RP-Amide |
166 |
| Antimicrobial Furazolidone Using Ascentis RP-Amide, Analysis of |
157 |
| Antineoplastic Drug Mitoxantrone Using Ascentis RP-Amide, Analysis o |
257 |
| Antineoplastic Drug Mitoxantrone and Degradation Product Using Ascentis RP-Amide, Analysis of |
258 |
| Antineoplastic Methotrexate Using Ascentis RP-Amide, Analysis of |
160 |
| Antipsychotics Using Ascentis RP-Amide, Analysis of |
139 |
| Antiretrovirals Using Ascentis RP-Amide, Separation of |
262 |
| Antiulceratives Using Ascentis RP-Amide, Analysis of |
234 |
| Antiviral Nevirapine Using Ascentis RP-Amide, Analysis of |
238 |
| Anxiolytic Chlordiazepoxide Using Ascentis RP-Amide, Analysis of |
154 |
| Aromatic Compounds Using Ascentis RP-Amide, Separation of |
140 |
| Ascorbic Acid and Dehydroascorbic Acid Using Ascentis RP-Amide, Analysis of |
193 |
| Atrazine Metabolites Using Ascentis RP-Amide, Analysis of |
256 |
| Barbitals Using Ascentis RP-Amide, Analysis of |
217 |
| Benzoic acid derivatives Using Ascentis RP-Amide, Analysis of |
146 |
| Bronchiodialator Terbutaline Using Ascentis RP-Amide, Analysis of |
169 |
| Calcium Channel Blocker Verapamil and Methoxy Metabolite Using Ascentis RP-Amide, Analysis of |
170 |
| Catechols and Resorcinols Using Ascentis RP-Amide, Separation of |
141 |
| Cephalosporins Cefadroxil, Cephapirin, and Cefsulodin Using Ascentis RP-Amide, Analysis of |
151 |
| Cephalosporins Cefoxitin and Cephalothin Using Ascentis RP-Amide, Analysis of |
152 |
| Cephalosporins Cefprozil Z Isomer and Ceftriaxone Using Ascentis RP-Amide, Analysis of |
153 |
| Cholesterol Lowering Drugs Using Ascentis RP-Amide, Analysis of |
329 |
| Codeines Using Ascentis RP-Amide, Analysis of |
155 |
| Cold Remedy Ingredients Using Ascentis RP-Amide, Analysis of |
236 |
| Common Cold Remedy Ingredients Using Ascentis RP-Amide, Analysis of |
267 |
| Diuretics Furosemide and Indapamide Using Ascentis RP-Amide, Analysis of |
158 |
| Estrone, β-Estradiol, α-Estradiol, and Estriol Using Ascentis RP-Amide, Analysis of |
179 |
| Floxacin Antibacterials Using Ascentis RP-Amide, Analysis of |
163 |
| Herbicide Triazines Using Ascentis RP-Amide, Analysis of |
224 |
| Hydrobenzoic acids, Hydroxycinnamic Acids and Flavonoids Using Ascentis RP-Amide, Analysis of |
271 |
| Hydrophobic Bases Using Ascentis RP-Amide, Separation of |
142 |
| Hydrophobic Peptide Probes Using Ascentis RP-Amide, Analysis of |
189 |
| 4-hydroxytamoxifen Isomers Using Ascentis RP-Amide, Analysis of |
345 |
| Nevirapine and Pirenzepine Using Ascentis RP-Amide, Analysis of the Structurally Similar Compounds |
259 |
| Nitrazepam Anticonvulsant Using Ascentis RP-Amide, Analysis of |
162 |
| Non-steroidal Anti-inflammatory Drugs (NSAIDS) Diclofenac and Salicylic Acid Using Ascentis RP-Amide, Analysis of |
144 |
| Non-steroidal Anti-inflammatory Drugs (NSAIDS) Using Ascentis RP-Amide, Analysis of |
145 |
| Nucleobases Using Ascentis RP-Amide, Analysis of |
269 |
| Oxidized and Reduced Glutathione on Ascentis RP-Amide, Resolution of |
237 |
| Parabens Using Ascentis RP-Amide, Analysis of |
207 |
| Penicillins Using Ascentis RP-Amide, Analysis of |
164 |
| 5 Peptide Mixture Using Ascentis RP-Amide, Separation of |
143 |
| Pesticides Aldicarb, Carbofuran, and Atrazine Using Ascentis RP-Amide, Analysis of |
215 |
| Pesticides Carbaryl, Diuron, and Propachlor Using Ascentis RP-Amide, Analysis of |
209 |
| Phenolic and Benzyl Compounds Using Ascentis RP-Amide, Analysis of |
226 |
| Phenolic Antioxidants Using Ascentis RP-Amide, Analysis of |
288 |
| 1-(2-pyridyl)-piperazine (2PP) Derivatives of Di-isocyanates Using Ascentis RP-Amide |
220 |
| Quinidine and its Derivatives Using Ascentis RP-Amide, Analysis of |
147 |
| Ribavirin and Related Degradants Using Ascentis RP-Amide, Separation of |
273 |
| Ribavirin Using Ascentis RP-Amide, Analysis of |
274 |
| Serum-derived Peptide Probes Using Ascentis RP-Amide, Analysis of |
191 |
| Steroids Using Ascentis RP-Amide, Analysis of |
181 |
| Sulfonylurea Urea Pesticides Using Ascentis RP-Amide, Analysis of |
242 |
| Tetracyclines Using Ascentis RP-Amide, Analysis of |
261 |
| Tranquilizer Fentanyl Citrate Using Ascentis RP-Amide, Analysis of |
156 |
| Tricyclic Antidepressants Using Ascentis RP-Amide, Analysis of |
240 |
| Ulcer Treatment Drugs Using Ascentis RP-Amide, Analysis of |
264 |
| Urea Pesticides Using Ascentis RP-Amide, Analysis of |
211 |
| Vitamin D2 and Vitamin D3 Using Ascentis RP-Amide, Analysis of |
213 |
| Warfarin Anticoagulant Using Ascentis RP-Amide, Analysis of |
149 |
| Water Soluble Vitamins Using Ascentis RP-Amide, Separation of |
278 |
|
|
| Ascentis RP-Amide, LC-MS / LC-UV |
back to top |
| Anesthetic Phencyclidine and Hydroxy Metabolite Using Ascentis RP-Amide, LC-MS Analysis of |
165 |
| Antimicrobial Therapeutic Carbadox Using Ascentis RP-Amide, LC-MS Analysis of |
204 |
| Antimicrobial Therapeutic Carbadox Using Ascentis RP-Amide, LC-UV Analysis of |
205 |
| Cannabinoids on Ascentis RP-Amide, LC-MS Analysis of |
188 |
| Carotene Compounds on Ascentis RP-Amide, LC-MS Analysis of |
293 |
| Carotene Compounds on Ascentis RP-Amide, LC-UV Analysis of |
294 |
| Catechins Using Ascentis RP-Amide, LC-MS Analysis of |
194 |
| Complex Peptide Mixture Using Ascentis RP-Amide, LC-MS Analysis of |
174 |
| Fatty Acids Using Ascentis RP-Amide, LC-MS Analysis of |
228 |
| Sucralose and Sucrose Octacetate on Ascentis RP-Amide, LC-MS Analysis of |
266 |
| |
|
